Full text
PDFPage 478
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barnes D. M., Harris W. H., Smith P., Millis R. R., Rubens R. D. Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. Br J Cancer. 1996 Nov;74(9):1445–1451. doi: 10.1038/bjc.1996.563. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Colditz G. A. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst. 1998 Jun 3;90(11):814–823. doi: 10.1093/jnci/90.11.814. [DOI] [PubMed] [Google Scholar]
- Holli K., Isola J., Cuzick J. Low biologic aggressiveness in breast cancer in women using hormone replacement therapy. J Clin Oncol. 1998 Sep;16(9):3115–3120. doi: 10.1200/JCO.1998.16.9.3115. [DOI] [PubMed] [Google Scholar]
- Robbins P., Pinder S., de Klerk N., Dawkins H., Harvey J., Sterrett G., Ellis I., Elston C. Histological grading of breast carcinomas: a study of interobserver agreement. Hum Pathol. 1995 Aug;26(8):873–879. doi: 10.1016/0046-8177(95)90010-1. [DOI] [PubMed] [Google Scholar]
- Willis D. B., Calle E. E., Miracle-McMahill H. L., Heath C. W., Jr Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States. Cancer Causes Control. 1996 Jul;7(4):449–457. doi: 10.1007/BF00052671. [DOI] [PubMed] [Google Scholar]